XML 24 R6.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Changes in Equity - USD ($)
$ in Millions
Total
Treasury shares at cost 
Share- 
based 
payments and other reserves
Retained earnings
Accumulated other comprehensive income (loss)
Equity 
attributable 
to 
shareholders 
of Fairfax
Non- 
controlling 
interests
Multiple voting shares
Equity issued
[2]
Common shareholders’ equity
Equity issued
Preferred 
shares
Equity issued
Canada 
Canada 
Accumulated other comprehensive income (loss)
[1]
Canada 
Equity 
attributable 
to 
shareholders 
of Fairfax
Canada 
Common shareholders’ equity
Equity issued
Europe
Europe
Accumulated other comprehensive income (loss)
[1]
Europe
Equity 
attributable 
to 
shareholders 
of Fairfax
Europe
Common shareholders’ equity
Equity issued
European Run-off
Accumulated other comprehensive income (loss)
Beginning balance at Dec. 31, 2018 $ 17,365.2 $ (587.5) $ 208.9 $ 5,864.2 $ (565.3) [1] $ 13,114.8 $ 4,250.4 $ 6,859.0 $ 11,779.3 $ 1,335.5                  
Changes in equity [abstract]                                      
Net earnings (loss) for the year 1,971.2     2,004.1   2,004.1 (32.9)   2,004.1   $ 104.1                
Net unrealized foreign currency translation gains (losses) on foreign operations 101.4       118.3 [1] 118.3 (16.9)   118.3                    
Losses on hedge of net investment                     (105.6) $ (105.6) $ (105.6) $ (105.6) $ (35.3) $ (35.3) $ (35.3) $ (35.3)  
Share of other comprehensive income of associates, excluding net losses on defined benefit plans (37.7)       (17.6) [1] (17.6) (20.1)   (17.6)                    
Net unrealized foreign currency translation losses reclassified to net earnings 0.0                                    
Net losses on defined benefit plans (69.3)       (69.4) [1] (69.4) 0.1   (69.4)                    
Share of net losses on defined benefit plans of associates (41.3)       (36.8) [1] (36.8) (4.5)   (36.8)                    
Issuances for share-based payments (5.1) 30.8 (35.6)     (4.8) (0.3)   (4.8)                    
Purchases and amortization for share-based payments (note 16) (19.0) (104.4) 80.1     (24.3) 5.3   (24.3)                    
Purchases for cancellation (note 16) (118.0)     (56.2)   (118.0)   (61.8) (118.0)                    
Common share dividends (note 16) (453.8)     (278.0)   (278.0) (175.8)   (278.0)                    
Preferred share dividends (note 16) (45.8)     (45.8)   (45.8)     (45.8)                    
Acquisitions of subsidiaries (note 23) 121.7           121.7                        
Deconsolidation of subsidiary (note 23) (466.2)           (466.2)                        
Other net changes in capitalization (note 16) (255.2)   (14.4) (109.1) 0.0 [1] (123.5) (131.7)   (123.5)                    
Ending balance at Dec. 31, 2019 17,907.2 (661.1) 239.0 7,379.2 (711.7) [1] 14,378.1 3,529.1 6,797.2 13,042.6 1,335.5                 $ (127.5)
Changes in equity [abstract]                                      
Net earnings (loss) for the year 37.4     218.4   218.4 (181.0)   218.4   91.6                
Net unrealized foreign currency translation gains (losses) on foreign operations (139.7)       (117.2) [1] (117.2) (22.5)   (117.2)                    
Losses on hedge of net investment                     $ (38.0) $ (38.0) $ (38.0) $ (38.0) $ (75.8) $ (75.8) $ (75.8) $ (75.8)  
Share of other comprehensive income of associates, excluding net losses on defined benefit plans 67.4       38.8 [1] 38.8 28.6   38.8                    
Net unrealized foreign currency translation losses reclassified to net earnings 188.7       188.7 [1] 188.7     188.7                    
Net losses on defined benefit plans (67.5)       (66.0) [1] (66.0) (1.5)   (66.0)                    
Share of net losses on defined benefit plans of associates (51.1)       (45.9) [1] (45.9) (5.2)   (45.9)                    
Issuances for share-based payments (12.0) 56.7 (66.5)     (9.8) (2.2)   (9.8)                    
Purchases and amortization for share-based payments (note 16) (48.1) (137.9) 84.3     (53.6) 5.5   (53.6)                    
Purchases for cancellation (note 16) (100.9)     (15.7)   (100.9)   (85.2) (100.9)                    
Common share dividends (note 16) (441.3)     (275.7)   (275.7) (165.6)   (275.7)                    
Preferred share dividends (note 16) (44.0)     (44.0)   (44.0)     (44.0)                    
Acquisitions of subsidiaries (note 23) 92.9           92.9                        
Deconsolidation of subsidiary (note 23) 255.7 9.5 (10.9) (53.2) 28.0 [1] (26.6) 282.3   (26.6) 0.0                  
Other net changes in capitalization (note 16) (3.6)   2.5 (116.5) 0.1 (113.9) 110.3   (113.9)                    
Ending balance at Dec. 31, 2020 $ 17,527.3 $ (732.8) $ 248.4 $ 7,092.5 $ (799.0) [1] $ 13,856.6 $ 3,670.7 $ 6,712.0 $ 12,521.1 $ 1,335.5                  
[1] Accumulated other comprehensive loss at December 31, 2019 of $711.7 included European Run-off's loss of $127.5 related primarily to net unrealized foreign currency translation losses (note 23).
[2] Includes multiple voting shares with a carrying value of $3.8 at January 1, 2019, December 31, 2019 and December 31, 2020.